Scarica l'app Stockscreener
0.104
0.68%
0.0007
Precedente Chiudi:
$0.1033
Aprire:
$0.1002
Volume 24 ore:
23.41M
Relative Volume:
0.65
Capitalizzazione di mercato:
$14.40M
Reddito:
-
Utile/perdita netta:
$-27.39M
Rapporto P/E:
-0.0619
EPS:
-1.6803
Flusso di cassa netto:
$-2.09M
1 W Prestazione:
-24.03%
1M Prestazione:
+14.92%
6M Prestazione:
-68.10%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.096
$0.104
Intervallo di 1 settimana:
$0.09
$0.171
Portata 52W:
$0.0709
$2.10
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Nome
Aspire Biopharma Holdings Inc
Settore
Industria
Telefono
561-704-8527
Indirizzo
23150 FASHION DRIVE, SUITE 232, ESTERO
Confronta ASBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.104 | 14.30M | 0 | -27.39M | -2.09M | -1.6803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie
Aspire Biopharma Approves Key Proposals at Special Meeting - MSN
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - The Patriot Ledger
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member - St. Cloud Times
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin – Retail Expects Licensing Negotiations Soon - Stocktwits
FDA feedback clears path for Aspire Biopharma’s heart attack drug By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Aspire Biopharma stock soars after FDA meeting clears path for heart attack drug By Investing.com - Investing.com South Africa
Aspire Biopharma stock soars after FDA meeting clears path for heart attack drug - Investing.com Canada
FDA feedback clears path for Aspire Biopharma’s heart attack drug - Investing.com India
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA) - ACCESS Newswire
FDA backs trial of faster-acting aspirin powder for heart attacks - Stock Titan
Aspire Biopharma Provides Q3 2025 Business Update - Oak Ridger
Aspire Biopharma (ASBP) Competitors and Alternatives 2026 - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Aspire Biopharma Restructures Debt via Equity Exchange Agreements - TipRanks
Aspire Biopharma Holdings Signs Debt-for-Equity Exchange Agreements With Certain Debt Holders - TradingView — Track All Markets
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Asbury Park Press
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aspire Biopharma Holdings, Inc. Announces CEO Transition - aberdeennews.com
Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - Pensacola News Journal
Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs Revenue Breakdown – NASDAQ:ASBPW - TradingView — Track All Markets
Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs - TradingView — Track All Markets
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Bluffton Today
Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine - The Florida Times-Union
ASBPAI Stock Analysis - Meyka
Aspire Biopharma welcomes Ashley Paulson as Brand Ambassador - Comunicaffe International
Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Gl - The National Law Review
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aspire Biopharma names Ashley Paulson BUZZ BOMB global brand ambassador - TipRanks
Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching - ts2.tech
Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):